Table 3.

Predictive value of the metabolic syndrome, its components and insulin resistance for cardiovascular diseases

Cox models	C statistic			Integrated discrimination improvement			Net reclassification index
	Index	95% CI	P value	Index	95% CI	P value	Index	95% CI	P value
Poor CVH status
MetS
Model 1	0.682	0.648–0.715	<0.001
Model 2	0.684	0.651–0.717	<0.001	0.006	0.004–0.007	<0.001	0.13	0.05–0.16	0.0154
High TG
Model 1	0.682	0.648–0.715	<0.001
Model 2	0.687	0.654–0.720	<0.001	0.004	0.003–0.006	<0.001	0.12	0.05–0.17	0.0140
Low HDL‐C
Model 1	0.682	0.648–0.715	<0.001
Model 2	0.686	0.653–0.719	<0.001	0.005	0.0001–0.008	0.042	0.09	0.05–0.16	0.0362
Abdominal obesity
Model 1	0.682	0.648–0.715	<0.001
Model 2	0.679	0.645–0.713	<0.001	0.005	−0.003 to 0.013	0.241	0.09	−0.19 to 0.18	0.1662
Insulin resistance †
Model 1	0.682	0.648–0.715	<0.001
Model 2	0.696	0.647–0.744	<0.001	0.011	0.0002–0.021	0.045	0.11	0.06–0.18	0.04259
Intermediate CVH status
MetS
Model 1	0.759	0.742–0.775	<0.001
Model 2	0.760	0.744–0.777	<0.001	0.002	0.0007–0.004	0.005	0.14	0.10–0.21	0.03212
High TG
Model 1	0.759	0.742–0.775	<0.001
Model 2	0.759	0.743–0.776	<0.001	0.0006	−0.0004 to 0.001	0.265	0.07	−0.12 to 0.22	0.0862
Low HDL‐C
Model 1	0.759	0.742–0.775	<0.001
Model 2	0.760	0.744–0.776	<0.001	0.0007	0.0003–0.001	0.003	0.13	0.09–0.25	0.0123
Abdominal obesity
Model 1	0.759	0.742–0.775	<0.001
Model 2	0.756	0.739–0.772	<0.001	−0.0007	−0.003 to 0.002	0.612	0.09	−0.15 to 0.26	0.2652
Insulin resistance
Model 1	0.759	0.742–0.775	<0.001
Model 2	0.761	0.738–0.784	<0.001	0.0006	−0.001 to 0.002	0.478	0.10	−0.17 to 0.17	0.2159

^† Data were included for 3,433 participants.

HDL‐C, high density lipoprotein cholesterol; MetS, metabolic syndrome; TG, triglyceride.